Patents by Inventor Isaac Jesus Rondon

Isaac Jesus Rondon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Binding peptides for carcinoembryonic antigen (CEA)
    Patent number: 6919424
    Abstract: The present invention provides binding moieties for CEA, which have a variety of uses wherever detecting, isolating or localizing CEA, and particularly CEA as opposed to cross-reactive antigens such as NCA, is advantageous. Particularly disclosed are synthetic, isolated polypeptides capable of binding CEA, which is overexpressed in adenocarcinomas of endodermally derived digestive system epithelia and fetal colon. Such polypeptides and disclosed derivatives are useful, e.g., as imaging agents for CEA-expressing tumors.
    Type: Grant
    Filed: April 3, 2001
    Date of Patent: July 19, 2005
    Assignee: Dyax Corp.
    Inventors: Isaac Jesus Rondon, Robert Charles Ladner
  • Binding peptides for carcinoembryonic antigen (CEA)
    Patent number: 6774209
    Abstract: The present invention provides binding moieties for CEA, which have a variety of uses wherever detecting, isolating or localizing CEA, and particularly CEA as opposed to cross-reactive antigens such as NCA, is advantageous. Particularly disclosed are synthetic, isolated polypeptides capable of binding CEA, which is overexpressed in adenocarcinomas of endodermally derived digestive system epithelia and fetal colon. Such polypeptides and disclosed derivatives are useful, e.g., as imaging agents for CEA-expressing tumors.
    Type: Grant
    Filed: April 3, 2000
    Date of Patent: August 10, 2004
    Assignee: Dyax Corp.
    Inventors: Isaac Jesus Rondon, Robert Charles Ladner
  • Binding peptides for carcinoembryonic antigen (CEA)
    Publication number: 20030203415
    Abstract: The present invention provides binding moieties for CEA, which have a variety of uses wherever detecting, isolating or localizing CEA, and particularly CEA as opposed to cross-reactive antigens such as NCA, is advantageous. Particularly disclosed are synthetic, isolated polypeptides capable of binding CEA, which is overexpressed in adenocarcinomas of endodermally derived digestive system epithelia and fetal colon. Such polypeptides and disclosed derivatives are useful, e.g., as imaging agents for CEA-expressing tumors.
    Type: Application
    Filed: April 3, 2001
    Publication date: October 30, 2003
    Inventors: Isaac Jesus Rondon, Robert Charles Ladner
  • Binding molecules for Fc-region polypeptides
    Publication number: 20030199671
    Abstract: Binding molecules for detecting or isolating immunoglobulin Fc-region polypeptides are described, together with methods of use thereof. Preferred Fc-region binding polypeptides, recombinant bacteriophage expressing Fc-region binding polypeptides, and separation media exhibiting such polypeptides are particularly disclosed.
    Type: Application
    Filed: April 18, 2002
    Publication date: October 23, 2003
    Inventors: Isaac Jesus Rondon, Qi-Long Wu, Arthur C. Ley, Mark Stochl, Thomas C. Ransohoff, M. Daniel Potter, Marilou Potter